Hemp Access Update

A quick, nonpartisan update on hemp-derived cannabinoids, CBD, and what we’re watching next.

Over the past year, customers have asked a simple question: will safe, regulated hemp-derived products remain available to adults. Recent federal action and public discussion suggest a shift toward regulation and clarity rather than a blanket ban.

We’re encouraged to hear more medical voices speaking publicly about cannabinoids, including CBD, especially for common quality-of-life issues like sleep, stress, and discomfort. At the same time, the policy landscape is still evolving, and details matter.

Our Position

• Protect minors. Age limits should be real and enforceable.
• Protect consumers. Mandatory third-party lab testing, clear labeling, and child-resistant packaging.
• Support transparency. Reasonable limits and consistent standards for finished products.
• Reject prohibition. Prohibition pushes people toward unregulated, unsafe alternatives.

Our View on Cannabinoids, Potency, and Safety

Hemp-derived cannabinoids serve a wide range of adult needs, from mild relaxation to meaningful symptom relief. We believe responsible regulation should reflect how these products are actually used in the real world.

In our experience, adults safely self-regulate their intake. Some prefer lower-dose options. Others require higher potency to achieve relief due to tolerance, metabolism, or specific quality-of-life concerns. Clear labeling, education, and age restrictions make this possible.

We reject the idea that “medical” and “recreational” cannabis are separate categories. The same effects that produce euphoria—relaxation, mood elevation, appetite support, improved sleep—are often the very effects people seek for legitimate wellness and medical reasons.

Policies that ban flower or impose unrealistically low dosage limits do not reduce use. They push consumers toward unregulated markets and undermine safety. A regulated environment with transparent labeling and flexible dosing better protects adults and communities.

We support standards that prioritize safety, clarity, and adult choice—not prohibition.

CBD, THC, and the Reality of How People Use Cannabinoids

Many adults benefit from CBD alone, with little or no THC. We respect that, we carry those products, and we believe they should remain widely available.

At the same time, decades of real-world use—and a growing body of research—show that many people find the greatest benefit when CBD and THC are used together. This interaction, often referred to as the entourage effect, reflects how cannabinoids naturally occur in the plant and how they have historically been used.

In public policy discussions, CBD is often highlighted while THC is treated as something separate or suspect. In our view, this division is largely artificial. CBD and THC come from the same plant, serve overlapping purposes, and are frequently used together by adults seeking relaxation, relief, improved sleep, appetite support, or stress reduction.

We do not believe CBD and THC should be treated as entirely separate industries. Doing so misrepresents how cannabinoids actually work and how people responsibly use them. A thoughtful regulatory framework should acknowledge both—allowing adults access to CBD-only products and to combination products that reflect real-world needs.

Recognizing the full spectrum of cannabinoids does not mean abandoning safety. It means regulating the whole plant honestly, with clear labeling, education, and age restrictions, rather than pretending that one part of the plant matters and the other does not.

What We’re Watching Next

• How federal agencies define and regulate finished hemp-derived cannabinoid products.
• Whether Congress pursues a framework that protects full-spectrum CBD while restricting truly unsafe products.
• How states respond, including licensing, testing requirements, and enforcement priorities.